#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Multiple system atrophy Hepatoblastoma Biotinidase deficiency Primitive neuroectodermal tumour Nephroblastoma Acute leukaemia Leukodystrophy Ventricular fibrillation Cardiac failure acute Peripheral primitive neuroectodermal tumour of soft tissue IPEX syndrome Insulinoma Retinitis pigmentosa Cryoglobulinaemia Follicular lymphoma stage I More trials…
Learn about Rare Diseases

Mantle cell lymphoma – Basic Information Adrenocortical carcinoma – Diagnostics Crigler-Najjar syndrome – Basic Information Loeys-Dietz syndrome – Life with Disease Cystic fibrosis – Treatment Hereditary neuropathic amyloidosis Primary immunodeficiency syndrome – Diagnostics Marfan’s syndrome – Treatment Mucopolysaccharidosis II – Treatment Krabbe’s disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Deoxyribonucleic Acid Tadalafil Bms-986288 Azd8421 Lasofoxifene AZD0120 Festuca Elatior Pollen Extract Dopamine Hydrochloride Teprenone Lorundrostat Abemaciclib Tinzaparin Sodium Lymecycline Oregovomab Acetylcysteine Amide Pitavastatin Calcium Hyoscine Butylbromide PHENTOLAMINE MESILATE GSK3862995B Repotrectinib More therapies…

Learn about Your Condition

Paraganglion neoplasm Embolism venous Hyperhidrosis Retroperitoneal fibrosis Cytomegalovirus infection Hyperinsulinism Carcinoid tumour pulmonary Pelvic venous thrombosis Micrographic skin surgery Choreoathetosis Thrombosis prophylaxis Tendon disorder Carotid arteriosclerosis Hyperparathyroidism secondary Post procedural hypotension More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Hairy cell leukaemia

Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

Recruiting

2 1 1 1
Investigated Diseases:
- Hairy cell leukaemia
Investigated Drugs:
Study of Obinutuzumab, Vemurafenib, and Cobimetinib for Hairy Cell Leukemia in Patients Previously Treated with Purine Analogs or Unfit for Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Hairy cell leukaemia
- Hairy cell leukaemia recurrent
Investigated Drugs:
Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Hairy cell leukaemia
Investigated Drugs:
+1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hairy cell leukaemia

Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

Study of Obinutuzumab, Vemurafenib, and Cobimetinib for Hairy Cell Leukemia in Patients Previously Treated with Purine Analogs or Unfit for Chemotherapy

Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies